Latest News

© JHVEPhoto - ©  JHVEPhoto - stock.adobe.com
FDA Outlines Updated Requirement for Placebo-Controlled Trials in Vaccine Research

May 21st 2025

In an article recently published by The New England Journal of Medicine, FDA higher-ups Vinay Prasad, MD, MPH; and Martin A. Makary, MD, MPH, wrote that any new COVID-19 vaccine must now be evaluated in placebo-controlled studies.

Merck’s Oral TLR7/8 Inhibitor Reduces Disease Activity in Cutaneous, Systemic Lupus
Merck’s Oral TLR7/8 Inhibitor Reduces Disease Activity in Cutaneous, Systemic Lupus

May 21st 2025

FDA Advisory Committee Backs J&J’s Darzalex Faspro for High-Risk Smoldering Multiple Myeloma
FDA Advisory Committee Backs J&J’s Darzalex Faspro for High-Risk Smoldering Multiple Myeloma

May 21st 2025

Stock.adobe.com
GSK and Lifetime Produce Meningitis-Themed Film

May 21st 2025

Christopher Wooden
The Promise of Agentic AI to Cut Through HCP Marketing Overwhelm

May 21st 2025

How Does the Shift to Early-Stage M&A Change Due Diligence?

A well-defined scientific and strategic approach is critical for buyers in this dealmaking setting.

 A well-defined scientific and strategic approach is critical for buyers in this dealmaking setting.

Conference Coverage

View All
Asembia 2025: GLP-1 Drugs Reshape Reimbursement and Coverage Models
Asembia 2025: GLP-1 Drugs Reshape Reimbursement and Coverage Models

May 7th 2025

Asembia 2025: FDA Uncertainty Sparks Shift Toward Outsourced Pharma Support
Asembia 2025: FDA Uncertainty Sparks Shift Toward Outsourced Pharma Support

May 7th 2025

Asembia 2025: Digital Health and Biosimilars Shape the Future of Pharmacy
Asembia 2025: Digital Health and Biosimilars Shape the Future of Pharmacy

May 6th 2025

Asembia 2025: Tracking Long-Term Outcomes Key to Advanced Therapy Value
Asembia 2025: Tracking Long-Term Outcomes Key to Advanced Therapy Value

May 6th 2025

Latest Videos
Podcasts
Peter Ax, UpScriptHealth
Jennifer Butler

All News